Mandlige patienter og deres kvindelige partnere skal hver anvende en sikker præventionsform under behandlingen og i 7 måneder efter behandlingen er ophørt.
Male patients and their female partners must each use an effective contraceptive during treatment and for 7 months after treatment has been concluded.